Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomere Shortening | 2 | 2021 | 33 | 0.750 |
Why?
|
| Sirtuins | 1 | 2019 | 22 | 0.580 |
Why?
|
| Liver Cirrhosis | 2 | 2021 | 899 | 0.460 |
Why?
|
| Mitochondria | 4 | 2017 | 776 | 0.380 |
Why?
|
| Telomere | 3 | 2021 | 218 | 0.380 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 192 | 0.340 |
Why?
|
| Telomerase | 3 | 2019 | 153 | 0.300 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 722 | 0.280 |
Why?
|
| Chromatin | 2 | 2022 | 500 | 0.270 |
Why?
|
| Aging | 2 | 2012 | 1244 | 0.260 |
Why?
|
| Telomere Homeostasis | 2 | 2019 | 48 | 0.230 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2024 | 63 | 0.200 |
Why?
|
| Collagen Type VI | 1 | 2021 | 7 | 0.180 |
Why?
|
| Hepatic Stellate Cells | 1 | 2021 | 30 | 0.170 |
Why?
|
| Protein Subunits | 1 | 2021 | 158 | 0.170 |
Why?
|
| Cullin Proteins | 1 | 2020 | 13 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2021 | 142 | 0.160 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 187 | 0.160 |
Why?
|
| Hematopoiesis | 1 | 2021 | 213 | 0.150 |
Why?
|
| Fibrosis | 1 | 2021 | 419 | 0.150 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2019 | 4 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 186 | 0.150 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 37 | 0.150 |
Why?
|
| Claudins | 1 | 2018 | 29 | 0.140 |
Why?
|
| Muscle Proteins | 2 | 2018 | 400 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2896 | 0.140 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 57 | 0.140 |
Why?
|
| Peptides | 1 | 2021 | 705 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 242 | 0.140 |
Why?
|
| Mitosis | 1 | 2018 | 192 | 0.130 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2011 | 191 | 0.130 |
Why?
|
| Glioblastoma | 2 | 2012 | 372 | 0.130 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 404 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 254 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2019 | 649 | 0.130 |
Why?
|
| Animals | 14 | 2021 | 33856 | 0.130 |
Why?
|
| Cell Movement | 2 | 2018 | 875 | 0.120 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 54 | 0.120 |
Why?
|
| HEK293 Cells | 1 | 2019 | 806 | 0.120 |
Why?
|
| Mice | 11 | 2021 | 18215 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4713 | 0.110 |
Why?
|
| Signal Transduction | 7 | 2021 | 4669 | 0.110 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 241 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 2010 | 0.110 |
Why?
|
| p21-Activated Kinases | 2 | 2018 | 57 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 736 | 0.100 |
Why?
|
| RNA-Binding Proteins | 2 | 2024 | 538 | 0.100 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 1946 | 0.090 |
Why?
|
| Genes, Essential | 1 | 2012 | 38 | 0.090 |
Why?
|
| Genes, myc | 2 | 2022 | 96 | 0.090 |
Why?
|
| Liver | 1 | 2019 | 1789 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2017 | 795 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3823 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 1004 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 194 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2012 | 517 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2011 | 130 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 384 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2018 | 382 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2010 | 191 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2011 | 449 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2463 | 0.070 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 19 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2020 | 2420 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 542 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2010 | 588 | 0.070 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2008 | 72 | 0.070 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2008 | 12 | 0.070 |
Why?
|
| Mice, Nude | 3 | 2018 | 699 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2017 | 354 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 422 | 0.070 |
Why?
|
| Carcinogens | 1 | 2008 | 128 | 0.070 |
Why?
|
| Models, Biological | 1 | 2012 | 1383 | 0.060 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 526 | 0.060 |
Why?
|
| Humans | 12 | 2022 | 130555 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2602 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2010 | 1919 | 0.060 |
Why?
|
| Stem Cells | 1 | 2010 | 705 | 0.060 |
Why?
|
| Cyclophilin A | 1 | 2024 | 14 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 1218 | 0.050 |
Why?
|
| Mutation | 1 | 2017 | 6093 | 0.050 |
Why?
|
| Proteasome Inhibitors | 1 | 2022 | 53 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1307 | 0.050 |
Why?
|
| Apoptosis | 2 | 2021 | 1832 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3717 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 238 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2021 | 122 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2021 | 48 | 0.040 |
Why?
|
| Megakaryocytes | 1 | 2021 | 40 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 135 | 0.040 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 176 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 127 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2008 | 904 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2020 | 129 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2020 | 174 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 485 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 199 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 450 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2018 | 6 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 27 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 25 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2020 | 691 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 66 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Phenotype | 3 | 2017 | 4478 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 59 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 630 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 360 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 350 | 0.030 |
Why?
|
| Heterografts | 1 | 2018 | 191 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 565 | 0.030 |
Why?
|
| Receptors, Estrogen | 2 | 2012 | 731 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 356 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 1547 | 0.030 |
Why?
|
| DNA Damage | 2 | 2011 | 510 | 0.030 |
Why?
|
| Male | 3 | 2019 | 64534 | 0.030 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.030 |
Why?
|
| Proteogenomics | 1 | 2018 | 111 | 0.030 |
Why?
|
| Female | 3 | 2019 | 70425 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1656 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 128 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1367 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 3383 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2017 | 245 | 0.030 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 284 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1572 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 616 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 763 | 0.030 |
Why?
|
| Phosphonoacetic Acid | 1 | 2012 | 2 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 23 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 60 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2012 | 23 | 0.020 |
Why?
|
| Calcium | 1 | 2017 | 1020 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 145 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1000 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 358 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 1804 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 198 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 94 | 0.020 |
Why?
|
| Cardiac Volume | 1 | 2011 | 17 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 2012 | 60 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2011 | 36 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 63 | 0.020 |
Why?
|
| Chloroquine | 1 | 2011 | 30 | 0.020 |
Why?
|
| Enzyme Reactivators | 1 | 2010 | 2 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 110 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 37 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 535 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2011 | 151 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 255 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 665 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 61 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 415 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 243 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 130 | 0.020 |
Why?
|
| Smell | 1 | 2010 | 103 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 410 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 559 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 576 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2010 | 130 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 493 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 348 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 453 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 159 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 692 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2008 | 53 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 78 | 0.020 |
Why?
|
| Epidermis | 1 | 2008 | 61 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 710 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2008 | 169 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 479 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1586 | 0.010 |
Why?
|
| Genomics | 1 | 2008 | 1616 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 3407 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 3170 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 2985 | 0.010 |
Why?
|